SCHEMBL7412702

SCHEMBL7412702

COc1cc2c(C)nc(O)c([N+](=O)[O-])c2cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
TDP1 Q9NUW8 3/20 0.44
MAPT P10636 3/20 0.44
BLM P54132 1/20 0.44
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
PKM P14618 1/20 0.39
LMNA P02545 2/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
POLB P06746 3/20 0.39
GAA P10253 3/20 0.39
RAC1 P63000 2/20 0.39
CTDSP1 Q9GZU7 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
PDE4A P27815 1/20 0.38
PDE4D Q08499 1/20 0.38
ALDH1A1 P00352 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9830708 0.91 MEN1 (0.44) KDM4ETDP1MAPTBLMMEN1
SCHEMBL10787345 0.88 PDE3B (0.48) KDM4ETDP1MAPTBLMMEN1
SCHEMBL7409180 0.79 MAPT (0.43) KDM4ETDP1MAPTBLMMEN1
SCHEMBL7439631 0.79 MAPT (0.40) KDM4ETDP1MAPTBLMMEN1
SCHEMBL7414190 0.75 KDM4E (0.39) KDM4ETDP1MAPTBLMMEN1
SCHEMBL7437559 0.75 KMT2A (0.41) KDM4ETDP1MAPTBLMMEN1
SCHEMBL6313239 0.75 KDM4E (0.49) KDM4EMAPTMEN1KMT2APOLB
SCHEMBL7441183 0.73 LMNA (0.39) KDM4ETDP1MAPTBLMMEN1
SCHEMBL7411233 0.73 ABCG2 (0.48) TDP1MAPTMEN1KMT2AALDH1A1
SCHEMBL16563437 0.73 ALDH1A1 (0.46) KDM4ETDP1MAPTPKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252721-B1 4-NITROGEN SUBSTITUTED ISOQUINOLINOL COMPOUNDS HAVING CARDIOTONIC, PHOSPHODIESTERASE FRACTION III INHIBITING PROPERTIES AND/OR RENAL VASODILATING PROPERTIES ORTHO PHARMACEUTICAL CORPORATION (US) 1991-10-02 EP disclosed
US-4880817-A O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-11-14 US disclosed
US-4843077-A Isoquinoline derivatives having renal vasodilating properties and/or cardiotonic properties and/or phosphodiesterase inhibiting properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-06-27 US disclosed
CN-87105724-A Have cardiac stimulant, suppress the different hydroxyquinoline compounds that the 4-nitrogen of the character of phosphodiesterase part III and/or kidney vasorelaxation character replaces 1988-03-09 CN disclosed
EP-0252721-A1 4-Nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1988-01-13 EP disclosed
US-4714705-A 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1987-12-22 US disclosed